10 Tips for Breast Cancer Screening and Early Detection
Early detection offers the best chance for a cure.
Back on the Horse: Ron Rogers
You'd never know that Rogers has had multiple myeloma for almost 11 years -- and that's just the way he likes it.
Updates on Multiple Myeloma Diagnosis and Treatment Strategies
Progress in our understanding of multiple myeloma pathogenesis has led to the identification of new therapeutic targets.
Denosumab: A Review of Its Pharmacology and Clinical Implications
It is estimated that approximately 80% of all patients with diagnoses of breast cancer, prostate cancer, or multiple myeloma will develop bone metastases at some time during the course of their disease.
Evolving Strategies Using Hematopoietic Stem Cell Transplantation in Diffuse Large B-Cell Non-Hodgkin Lymphoma
Diffuse large B-cell non-Hodgkin lymphoma is typically a chemotherapy-sensitive malignancy, justifying dose-intense therapy with hematopoietic stem cell transplantation for patients unlikely to achieve cure with standard-dose regimens.
Accelerating Changes in Oncology
A look at dramatic changes in the landscape of multiple myeloma that have occurred over the past decade and new developments in the context of stem cell transplantation in non-Hodgkin lymphoma.
Endocrine Therapy Response Status Is Necessary for Treatment Planning in HR+/HER2– Early Breast Cancer
Neoadjuvant Nivolumab Plus Carboplatin/Paclitaxel Elicits High pCR Rates in Early-Stage TNBC
Dr Schmid on the Use of Perioperative Pembrolizumab in TNBC
Dr Khan on Optimizing Local Therapy Using MRI and a 12-Gene Expression Assay in DCIS
2 Clarke Drive Cranbury, NJ 08512